Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults

This study has been suspended.

( Based on an interim data review, the DSMB concluded that the vaccine cannot be shown in this trial to prevent HIV infection or affect the course of the disease. )

Study NCT00486408 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: June 12, 2007 Last Updated: September 9, 2008 History of Changes

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study has been suspended.
Estimated Study Completion Date:	May 2012
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)